Method

Nine fresh frozen cadaveric hips were used and primary THA was undertaken via a direct anterior approach. Before implantation of the components varying amounts of fluorescent powder (GloGerm) were deposited, simulating bacterial infection. Second, a one-step exchange was performed via a posterolateral approach. After implant removal, debridement, and lavage, randomization determined which clean phase protocol was followed, i.e. no, some or full additional measures. Finally, the new prosthesis was re-implanted (fig. 1).

In order to determine the effect of different clean phase protocols on contamination of the sterile field standardized UV light-enhanced photographs were obtained of 1) the gloves, 2) the instrument table, 3) the drapes, and 4) the wound and these were ranked on cleanliness by a blind panel of hip surgeons.

In order to determine whether or not it is possible to re-implant the prosthesis completely clean, the implant was taken out again at the end of the one-step exchange and inspected for contamination under UV light.

Methods:

Between January 1995 and October 1997, 245 consecutive total knee arthroplasties were performed in 217 patients by a single surgeon. In 156 knees, the Genesis I implant was used, and in 89 knees the Genesis II implant was used. Mean age at surgery was 69.3 years for the Genesis I cohort and 66 years for the Genesis II (p = 0.016). At 15 to 17 years, cumulative survivorship was calculated using Kaplan-Meier statistics whilst outcomes were rated with the ‘Knee society score’ and with the ‘Knee Injury and Osteoarthritis Outcome Score’. Radiological assessment included coronal alignment measured on full leg standing X-rays, and analysis of radiolucent lines and polyethylene thickness on AP, Lateral and Axial X-rays, positioned under fluoroscopic control.